← All organizations

AstraZeneca

For profitContributed to NMEWebsite ↗

Also known as: 1326 Riverview Road Ext Lexington, NC 27292-1764 USA | ALEXION PHARMS INC | AstraZeneca | ASTRAZENECA | AstraZeneca1800 Concord PikeWilmington, DE, 19850 | AstraZeneca 180 Concord Pike Wilmington, DE 19850-5437 | AstraZeneca 180 Concord Pike, Wilmington,DE 19850-5437 | AstraZeneca,1F64, Mereside, Alderley Park, Macclesfield, Cheshire,SK10 4TG UK | AstraZeneca AB | ASTRAZENECA AB | AstraZeneca Aderley Park | AstraZeneca AG, Grafenau 10; 6300 Zug; Switzerland | AstraZeneca Alderley Park | AstraZeneca, Alderley Park | AstraZeneca, Alderley Park, Cheshire, UK | Astrazeneca Alderley Park Macclesfield SK10 4TG United Kingdom | AstraZeneca, Alderley Park, UK | AstraZeneca Alderly Park1G61 Mereside, Alderly Park, Macclesfeld, Cheshire, England SK104TG | AstraZeneca Alderly Park CPU | Astrazeneca Alderly UK | AstraZeneca AS | AstraZeneca Barcelona | AstraZeneca, Biopharmaceuticals Medical | Astra Zeneca, Bristol-Myers Squibb | AstraZeneca, Bristol-Myers Squibb | AstraZeneca BV | AstraZeneca, Cambridge Science Park, US | AstraZeneca, Cambridge, UK | AstraZeneca Charnwood England | Astrazeneca China | AstraZeneca China MC | AstraZeneca, Clinical Pharamcology Unit, Alderley Park | AstraZeneca, Clinical Pharmacology Unit, Alderley Park | AstraZeneca Clinical Pharmacology Unit, AstraZeneca R&D Lund,Sweden | AstraZeneca, Clinical Pharmacology Unit at Sahlgrenska University Hospital, Sweden | AstraZeneca Clinical Pharmacology Unit, C2-84, Karolinska University Hospital Huddinge, Stockholm, Sweden | AstraZeneca Clinical Pharmacology Unit (CPU) C2:84Karolinska University Hospital HuddingeSE-141 86 StockholmSweden | AstraZeneca Clinical Pharmacology Unit, E Floor, Queens Medical Centre, Nottingham NG7 2UH | AstraZeneca Clinical Pharmacology Unit, Lund | AstraZeneca Clinical Pharmacology Unit, Nottingham | AstraZeneca Clinical Pharmacology Unit, Queens Medical Centre, Nottingham NG7 2UH | AstraZeneca, Clinical Pharmacology Unit, Sahlgrenska University Hospital | AstraZeneca Clinical Pharmacology Unit, Stockholm | Astrazeneca Clinical Pharmacology Unit, Stockholm, Sweden | AstraZeneca Clinical Pharmacology Unit, Stockholm, Sweden | AstraZeneca Clinical Pharmacology Unit, US | AstraZeneca CPU Alderley Park, United Kingdom | AstraZeneca CPU Huddinge | AstraZeneca CPU, Philadelphia | AstraZeneca CPU, Philadelphia, PA | AstraZeneca, Denmark | Astrazeneca (direct) | AstraZeneca employee | AstraZeneca Finland | AstraZeneca Germany | AstraZeneca Global Medicines Development, Academy House | AstraZeneca Global R&D, Alderley park, Cheshire, SK10 4TG, UK | AstraZeneca, Hertfordshire, UK | AstraZeneca Investment (China) Co., Ltd | AstraZeneca Japan | Astra Zeneca K.K. | AstraZeneca KK | AstraZeneca K.K. | AstraZeneca KK Corporate Communications | AstraZeneca KK - Pharmaceuticals | AstraZeneca Korea | AstraZeneca Kvambergagatan 12, 15185, Sodertalje, Sweden | AstraZeneca Kvzmbergagatan 12, 15185,Sodertalje, Sweden | ASTRAZENECA LP | AstraZeneca, LP, 1800 Concord Pike, Wilmington, DE | AstraZeneca, MC France | AstraZeneca MC Sweden | AstraZeneca Medical Science Director | AstraZeneca, Medical Science Director | AstraZeneca Mexico | AstraZeneca, Moelndal, Sweden | Astrazeneca Molndal, Sweden | Astrazeneca, Molndal, Sweden | AstraZeneca Molndal Sweden | AstraZeneca Molndal, Sweden | AstraZenecaMolndal Sweden | AstraZeneca NV/SA | AstraZeneca, Osaka, Japan | AstraZeneca, Parklands, Alderley Park | AstraZeneca,Parklands, Alderley Park | AstraZeneca, Pepparedsleden 1 431 83 Molndal Sweden | AstraZeneca Pharmaceutical | AstraZeneca Pharmaceutical Co., Ltd., Shanghai, China | AstraZeneca Pharmaceuticals 35 Gathouse Drive, Waltham, Ma 02451 United States | AstraZeneca Pharmaceuticals;C2C-716 1800 Concord PikePO. Box 15437Wilmington De 19850-5437 | AstraZeneca PharmaceuticalsC2C-7161800 Concord PikePO. Box 15437Wilmington De 19850-5437 | AstraZeneca PharmaceuticalsKvarnbergagatan 12, 15185, Sodertalje, Sweden | AstraZeneca Pharmaceuticals, Kvarnbergagatan 12S-151 85, Sodertalje, Sweden | AstraZeneca Pharmaceuticals PLC | AstraZeneca Pharmaceuticals Room C3B-718PO Box 15437 Wilmington, DE 19850-5437 USA | AstraZeneca PharmaceuticalsRoom C3B-718PO Box 15437Wilmington, DE 19850-5437 USA | AstraZeneca Pharmaceuticals-US | AstraZeneca Pharmaceuticals, Wilm DE | AstraZeneca Pharmaceuticals, Wilmington, DE 19850-5437 USA | AstraZeneca Pharmaceuticals, Wilmington, UK | ASTRAZENECA PHARMS | AstraZeneca R&D | AstraZeneca R&D, 35 Gatehouse Drive, MA 02451 USA | AstraZeneca R&D, Alderley Park, UK | AstraZeneca R&D Alderly Park, Mereside SK 104 TG Macclesfield, Cheshire United Kingdom | AstraZeneca R&D, Alderly Park, Mereside, SK 104TG, Macclesfield, Cheshire, United Kingdom | AstraZeneca R&D Alderly Park, Parklands, SK 104TF, Macclesfield, Cheshire, United Kingdom | AstraZeneca R&D BioPharmaceuticals | AstraZeneca R&D Boston | AstraZeneca R&D Boston, United States | AstraZeneca R&D Charnwood | AstraZeneca R&D, Charnwood, UK | AstraZeneca R&D, CPU Alderley Park, UK | AstraZeneca R&D CPU Karolinska University Hospital, Stockholm | AstraZeneca R&D CPU Nottingham, UK | AstraZeneca R&D, Gothenburg, Sweden | AstraZeneca R&D Japan | AstraZeneca R&D Lund | AstraZeneca R&D, Lund | AstraZeneca R&D Lund, Sweden | AstraZeneca R&D, Lund, Sweden | AstraZeneca, R&D, Lund, Sweden | AstraZeneca R&D Mölndal | AstraZeneca R&D Molndal | AstraZeneca R&D Molndal, Sweden | AstraZeneca R&D, Molndal Sweden | AstraZeneca R&DMolndal, Sweden | AstraZeneca R&D Sodertalje, SE-151 85 Sodertalje, Sweden | AstraZeneca R&D, Sodertalje, Sweden | AstraZeneca R&D, Wilmington | AstraZeneca R&D Wilmington, USA | AstraZeneca Research and Development SE-431 83 Molndal Sweden | AstraZeneca Research and DevelopmentSE-431 83 MolndalSweden | AstraZeneca Research & Development | AstraZeneca Research & Development, Neuroscience iMed, 141 Portland Street, Cambridge, MA 02139 | AstraZeneca Senior Research Physician | AstraZeneca Singapore Pte Ltd | Astrazeneca Sodertalje Sweden | Astrazeneca, Sodertalje Sweden | Astra Zeneca, Sodertalje, Sweden | AstraZeneca, Sodertalje Sweden | AstraZeneca Spain | AstraZeneca SpA, Medical Dept., Basiglio, ITALY | AstraZeneca Sponsor Research Physician | AstraZeneca Study Statistician | Astrazeneca Sweden | AstraZeneca Sweden | AstraZeneca Sweden AB | Astrazeneca UK | Astrazeneca, UK | AstraZeneca UK | AstraZeneca UK Limited | AstraZeneca UK Ltd | ASTRAZENECA UK LTD | AstraZeneca UK, MSD | Astrazeneca United kingdom | Astrazeneca, Waltham, MA, United States | AstraZeneca Wilmington | AstraZeneca Wilmington, DE United States | Astrazeneca Wilmington, US | Astrazeneca, Wilmington US | Astrazeneca, Wilmington, US | AstraZeneca Wilmington US | AstraZeneca, Wilmington US | AstraZeneca, Wilmington, US | AstraZeneca, Wilmington, USA | AstraZenenca | AZ | AZ Clinical Pharmacology Unit, Philadelphia, USA | AZD1386AstraZeneca R&D Wilmington, USA | AZ/Daiichi | AZ K.K | AZ K.K. | AZ Mondal R&D, Sweden | AZ Neuro | AZ Pharmaceuticals - China | AZ Pharmaceuticals - US | AZ Pharmaceuticals, US | AZ R&D Gaithersburg | AZ R&D, Gaithersburg | AztraZeneca, Tokyo, Japan | Bioventure Hub | Clinical Pharmacology UnitAlderley ParkAstraZenecaMacclesfieldSK10 4TG | Clinical Pharmacology Unit, AstraZeneca R&D Lund, Sweden | Cori Analyticals | Global Medicines Development | Medical Director AstraZeneca | Medical Director AstraZeneca goswamit@medimmune.com | Medical & Regulatory Affairs Director, AstraZeneca Greece: 4 | Medical Scientist AstraZeneca Anthony.Jarkowski@astrazeneca.com | Medicine and Sciences AstraZeneca | MedImmune, LLC | Molndal, Sweden AstraZeneca | Nexium Global Product Director, AstraZeneca | Physician Group, Clinical Division, R&D, Astrazeneca K.K. | Study Delievery Director, AstraZeneca | TOPROL | Wilmington, US AstraZeneca

Highest phase reached

Phase 4

First clinical trial

Jan 1, 1999

First marketed drug

Jan 1, 1999

First NDA

Feb 13, 2001

Last known activity

Oct 1, 2026

Timeline

1960s

  1. Apr 7, 1961

    amitriptyline— NDA Secondary Org

1990s

  1. Jan 1, 1999

    AstraZeneca— Founded

  2. Jan 1, 1999

    Astra— Acquired

  3. Jan 1, 1999

    Zeneca Pharmaceuticals— Acquired

2000s

  1. Dec 23, 2005

    KuDOS— Acquired

  2. Jan 1, 2006

    Cambridge Antibody Technology— Acquired

  3. Jan 1, 2007

    Arrow Therapeutics— Acquired

  4. Jun 19, 2007

    MedImmune— Acquired

  5. Dec 23, 2009

    Novexel Inc— Acquired

2010s

  1. Jan 1, 2012

    Ardea Biosciences— Acquired

  2. Jan 1, 2013

    AlphaCore Pharma LLC— Acquired

  3. Jan 1, 2013

    Amplimmune— Acquired

  4. Jan 1, 2013

    Pearl Therapeutics— Acquired

  5. Jan 1, 2013

    Spirogen— Acquired

  6. May 1, 2013

    Omthera Pharmaceuticals— Acquired

  7. Jan 1, 2014

    Allozyne— Acquired

  8. Jan 1, 2015

    Acerta Pharma— Acquired

  9. Jan 1, 2015

    Inovio Pharmaceuticals— Acquired

  10. Nov 6, 2015

    ZS Pharma, Inc.— Acquired

2020s

  1. Apr 10, 2020

    selumetinib— Marketing Organization

  2. Apr 10, 2020

    selumetinib— NDA Organization

  3. Oct 13, 2020

    Alexion— Acquired

  4. Jul 6, 2022

    TeneoTwo— Acquired

  5. Oct 3, 2022

    LogicBio Therapeutics— Acquired

  6. Jan 9, 2023

    CinCor Pharma, Inc.— Acquired

  7. Dec 12, 2023

    Icosavax, Inc.— Acquired

  8. Dec 26, 2023

    Gracell Biotechnology Ltd.— Acquired

  9. Mar 14, 2024

    Amolyt Pharma— Acquired

Drugs by trial phase (969 distinct, 4229 trials)

Indications

Studied for

Marketed drugs (68)

Subsidiaries (24 direct, 45 total across the full acquisition tree)

Recent trials (50)

Details

Founded
London, GB Jan 1, 1999
First NDA
Feb 13, 2001
Last known activity
Oct 1, 2026

Designations held

  • Orphan drug
  • Fast track
  • Priority review
  • Breakthrough therapy
  • Accelerated approval